568 related articles for article (PubMed ID: 19066282)
41. Apoptosis induced in synchronized human immunodeficiency virus type 1-infected primary peripheral blood mononuclear cells is detected after the peak of CD4+ T-lymphocyte loss and is dependent on the tropism of the gp120 envelope glycoprotein.
Lawson VA; Silburn KA; Gorry PR; Paukovic G; Purcell DF; Greenway AL; McPhee DA
Virology; 2004 Sep; 327(1):70-82. PubMed ID: 15327899
[TBL] [Abstract][Full Text] [Related]
42. Soluble gC1q-R/p33, a cell protein that binds to the globular "heads" of C1q, effectively inhibits the growth of HIV-1 strains in cell cultures.
Szabó J; Cervenák L; Tóth FD; Prohászka Z; Horváth L; Kerekes K; Beck Z; Bácsi A; Erdei A; Peerschke EI; Füst G; Ghebrehiwet B
Clin Immunol; 2001 May; 99(2):222-31. PubMed ID: 11318594
[TBL] [Abstract][Full Text] [Related]
43. HIV-1 envelope gp120 inhibits the monocyte response to chemokines through CD4 signal-dependent chemokine receptor down-regulation.
Wang JM; Ueda H; Howard OM; Grimm MC; Chertov O; Gong X; Gong W; Resau JH; Broder CC; Evans G; Arthur LO; Ruscetti FW; Oppenheim JJ
J Immunol; 1998 Oct; 161(8):4309-17. PubMed ID: 9780207
[TBL] [Abstract][Full Text] [Related]
44. Identification of determinants of interaction between CXCR4 and gp120 of a dual-tropic HIV-1DH12 isolate.
Lee MK; Heaton J; Cho MW
Virology; 1999 May; 257(2):290-6. PubMed ID: 10329539
[TBL] [Abstract][Full Text] [Related]
45. Properties of an ezrin mutant defective in F-actin binding.
Saleh HS; Merkel U; Geissler KJ; Sperka T; Sechi A; Breithaupt C; Morrison H
J Mol Biol; 2009 Jan; 385(4):1015-31. PubMed ID: 19084535
[TBL] [Abstract][Full Text] [Related]
46. Sulfatide inhibits HIV-1 entry into CD4-/CXCR4+ cells.
Fantini J; Hammache D; Delézay O; Piéroni G; Tamalet C; Yahi N
Virology; 1998 Jul; 246(2):211-20. PubMed ID: 9657940
[TBL] [Abstract][Full Text] [Related]
47. Dynamic interaction of VCAM-1 and ICAM-1 with moesin and ezrin in a novel endothelial docking structure for adherent leukocytes.
Barreiro O; Yanez-Mo M; Serrador JM; Montoya MC; Vicente-Manzanares M; Tejedor R; Furthmayr H; Sanchez-Madrid F
J Cell Biol; 2002 Jun; 157(7):1233-45. PubMed ID: 12082081
[TBL] [Abstract][Full Text] [Related]
48. Functional expression of CD4, CXCR4, and CCR5 in glycosphingolipid-deficient mouse melanoma GM95 cells and susceptibility to HIV-1 envelope glycoprotein-triggered membrane fusion.
Rawat SS; Eaton J; Gallo SA; Martin TD; Ablan S; Ratnayake S; Viard M; KewalRamani VN; Wang JM; Blumenthal R; Puri A
Virology; 2004 Jan; 318(1):55-65. PubMed ID: 14972535
[TBL] [Abstract][Full Text] [Related]
49. Actin cytoskeletal reorganizations and coreceptor-mediated activation of rac during human immunodeficiency virus-induced cell fusion.
Pontow SE; Heyden NV; Wei S; Ratner L
J Virol; 2004 Jul; 78(13):7138-47. PubMed ID: 15194790
[TBL] [Abstract][Full Text] [Related]
50. Fusion of monocytes and macrophages with HIV-1 correlates with biochemical properties of CXCR4 and CCR5.
Lapham CK; Zaitseva MB; Lee S; Romanstseva T; Golding H
Nat Med; 1999 Mar; 5(3):303-8. PubMed ID: 10086386
[TBL] [Abstract][Full Text] [Related]
51. Increased rate of HIV-1 entry and its cytopathic effect in CD4+/CXCR4+ T cells expressing relatively high levels of CD26.
Callebaut C; Jacotot E; Blanco J; Krust B; Hovanessian AG
Exp Cell Res; 1998 Jun; 241(2):352-62. PubMed ID: 9637777
[TBL] [Abstract][Full Text] [Related]
52. Cellular distributions of the ERM proteins in MDCK epithelial cells: regulation by growth and cytoskeletal integrity.
Woodward AM; Crouch DH
Cell Biol Int; 2001; 25(3):205-13. PubMed ID: 11352493
[TBL] [Abstract][Full Text] [Related]
53. Dynamic appearance of antigenic epitopes effective for viral neutralization during membrane fusion initiated by interactions between HIV-1 envelope proteins and CD4/CXCR4.
Toda T; Kuwahara K; Kondo N; Matsuda Z; Maeda Y; Maeda K; Sakaguchi N
Immunobiology; 2012 Sep; 217(9):864-72. PubMed ID: 22226668
[TBL] [Abstract][Full Text] [Related]
54. A novel mechanism for HIV1-mediated bystander CD4+ T-cell death: neighboring dying cells drive the capacity of HIV1 to kill noncycling primary CD4+ T cells.
Lelièvre JD; Mammano F; Arnoult D; Petit F; Grodet A; Estaquier J; Ameisen JC
Cell Death Differ; 2004 Sep; 11(9):1017-27. PubMed ID: 15118766
[TBL] [Abstract][Full Text] [Related]
55. Selective gene transfer to T lymphocytes using coreceptor-specific [MLV(HIV)] pseudotype vectors in a transgenic mouse model.
Schüle S; Steidl S; Panitz S; Coulibaly C; Kalinke U; Cichutek K; Schweizer M
Virology; 2006 Jul; 351(1):237-47. PubMed ID: 16650881
[TBL] [Abstract][Full Text] [Related]
56. Structural basis for the interaction between focal adhesion kinase and CD4.
Garron ML; Arthos J; Guichou JF; McNally J; Cicala C; Arold ST
J Mol Biol; 2008 Feb; 375(5):1320-8. PubMed ID: 18078954
[TBL] [Abstract][Full Text] [Related]
57. Role of CD4 hinge region in GP120 utilization by immunoglobulin domain 1.
Murray JL; Hu QX; Navenot JM; Peiper SC
Biochem Biophys Res Commun; 2002 Mar; 292(2):449-55. PubMed ID: 11906183
[TBL] [Abstract][Full Text] [Related]
58. Enhanced infection of an X4 strain of HIV-1 due to capping and colocalization of CD4 and CXCR4 induced by capsianoside G, a diterpene glycoside.
Song W; Yahara S; Maeda Y; Yusa K; Tanaka Y; Harada S
Biochem Biophys Res Commun; 2001 May; 283(2):423-9. PubMed ID: 11327719
[TBL] [Abstract][Full Text] [Related]
59. Proteomic analysis of the cellular responses induced in uninfected immune cells by cell-expressed X4 HIV-1 envelope.
Molina L; Grimaldi M; Robert-Hebmann V; Espert L; Varbanov M; Devaux C; Granier C; Biard-Piechaczyk M
Proteomics; 2007 Sep; 7(17):3116-30. PubMed ID: 17676665
[TBL] [Abstract][Full Text] [Related]
60. Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.
Zhao Q; Ma L; Jiang S; Lu H; Liu S; He Y; Strick N; Neamati N; Debnath AK
Virology; 2005 Sep; 339(2):213-25. PubMed ID: 15996703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
